Safety and Efficacy of A-007 Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix

PHASE2CompletedINTERVENTIONAL
Enrollment

147

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

April 30, 2008

Study Completion Date

June 30, 2008

Conditions
Cervical Intraepithelial NeoplasiaUterine Cervical Dysplasia
Interventions
DRUG

placebo

5 days of 28 day cycle for 2 cycles

DRUG

A007

5 days of 28 day cycle

Trial Locations (29)

10038

New York Downtown Hospital, New York

10461

Jacobi Medical Center, The Bronx

Montefiore Medical Center-Weiler Division Dept of OB/GYN & Women's Health, The Bronx

15213

Magee-Womens Hospital, Dept of OB/GYN & Reproductive Services, Pittsburgh

18102

Lehigh Valley Hospital, Allentown

20010

Washington Hospital Center, Washington D.C.

29210

South Carolina Oncology Associates, Columbia

30328

Mount Vernon Clinical Research, LLC, Atlanta

30912

Medical College of Georgia, Augusta

33024

Global OB/GYN Centers of Florida, Pembroke Pines

33401

OB/GYN Specialists of the Palm Beaches, West Palm Beach

33437

Visions Clinical Research, Boynton Beach

34239

Physician Care Clinical Research, LLC., Sarasota

35205

University of Alabama Highlands, Dept. of OB/GYN, Birmingham

45267

Greater Cincinnati OB/GYN, Inc., Cincinnati

70006

East Jefferson OB/GYN, Metairie

73104

University of Oklahoma Health Sciences Center Dept of OB/GYN, Oklahoma City

75093

4601 Old Shepard Place; Bldg 2, Suite 201, Plano

77004

Planned Parenthood of Houston & Southeast Texas, Inc., Houston

78737

Hill Country OB/GYN, Austin

85032

Hope Research Institute, LLC, Phoenix

85712

Visions Clinical Research-Tucson, Tucson

89128

Office of R. Garn Mabey, MD, Las Vegas

92121

IGO Medical Group of San Diego, San Diego

92324

Arrowhead Regional Medical Center, Colton

92629

Robin Black OGNP, Costa Mesa

95608

Northern California Research Corp, Carmichael

06320

Coastal Connecticut Research, LLC, New London

07754

Jersey Shore University Medical Center, Neptune City

Sponsors
All Listed Sponsors
lead

Tigris Pharmaceuticals

INDUSTRY

NCT00285207 - Safety and Efficacy of A-007 Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix | Biotech Hunter | Biotech Hunter